Acute Liver Failure Treatment Market, Global Outlook and Forecast 2022-2028

June 2022 | 64 pages | ID: A0BBA83E1E5FEN
Market Monitor Global

Abstracts

Acute liver failure is a rare condition. It happens when your liver suddenly begins to lose its ability to function. This often happens right after an overdose of medicine or poisoning. For acute (sudden) liver failure, treatment includes: Intravenous (IV) fluids to maintain blood pressure; Medications such as laxatives or enemas to help flush toxins (poisons) out; Blood glucose (sugar) monitoring; glucose is given to the patient if blood sugar drops.

This report contains market size and forecasts of Acute Liver Failure Treatment in Global, including the following market information:

Global Acute Liver Failure Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Acute Liver Failure Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hepatocyte Transplantation Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acute Liver Failure Treatment include Novartis AG, Bayer AG, Cardiorentis AG, Cytokinetics, Inc., Orion Corporation, Bristol-Myers Squibb Company, PhaseBio Pharmaceuticals, InC, Merck & Co and CVie Therapeutics Limited. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Liver Failure Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute Liver Failure Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acute Liver Failure Treatment Market Segment Percentages, by Type, 2021 (%)

• Hepatocyte Transplantation
• Assisted Liver Transplantation
• Xenotransplantation

Global Acute Liver Failure Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Acute Liver Failure Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Liver Academic and Research Institutes
• Forensic Laboratories

Global Acute Liver Failure Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acute Liver Failure Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Acute Liver Failure Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Acute Liver Failure Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Bayer AG
• Cardiorentis AG
• Cytokinetics, Inc.
• Orion Corporation
• Bristol-Myers Squibb Company
• PhaseBio Pharmaceuticals, InC
• Merck & Co
• CVie Therapeutics Limited

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Acute Liver Failure Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Acute Liver Failure Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACUTE LIVER FAILURE TREATMENT OVERALL MARKET SIZE

2.1 Global Acute Liver Failure Treatment Market Size: 2021 VS 2028
2.2 Global Acute Liver Failure Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Acute Liver Failure Treatment Players in Global Market
3.2 Top Global Acute Liver Failure Treatment Companies Ranked by Revenue
3.3 Global Acute Liver Failure Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Liver Failure Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acute Liver Failure Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Liver Failure Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Acute Liver Failure Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Acute Liver Failure Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Acute Liver Failure Treatment Market Size Markets, 2021 & 2028
  4.1.2 Hepatocyte Transplantation
  4.1.3 Assisted Liver Transplantation
  4.1.4 Xenotransplantation
4.2 By Type - Global Acute Liver Failure Treatment Revenue & Forecasts
  4.2.1 By Type - Global Acute Liver Failure Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Acute Liver Failure Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Acute Liver Failure Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Acute Liver Failure Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Liver Academic and Research Institutes
  5.1.5 Forensic Laboratories
5.2 By Application - Global Acute Liver Failure Treatment Revenue & Forecasts
  5.2.1 By Application - Global Acute Liver Failure Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Acute Liver Failure Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Acute Liver Failure Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Acute Liver Failure Treatment Market Size, 2021 & 2028
6.2 By Region - Global Acute Liver Failure Treatment Revenue & Forecasts
  6.2.1 By Region - Global Acute Liver Failure Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Acute Liver Failure Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Acute Liver Failure Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Acute Liver Failure Treatment Revenue, 2017-2028
  6.3.2 US Acute Liver Failure Treatment Market Size, 2017-2028
  6.3.3 Canada Acute Liver Failure Treatment Market Size, 2017-2028
  6.3.4 Mexico Acute Liver Failure Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Acute Liver Failure Treatment Revenue, 2017-2028
  6.4.2 Germany Acute Liver Failure Treatment Market Size, 2017-2028
  6.4.3 France Acute Liver Failure Treatment Market Size, 2017-2028
  6.4.4 U.K. Acute Liver Failure Treatment Market Size, 2017-2028
  6.4.5 Italy Acute Liver Failure Treatment Market Size, 2017-2028
  6.4.6 Russia Acute Liver Failure Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Acute Liver Failure Treatment Market Size, 2017-2028
  6.4.8 Benelux Acute Liver Failure Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Acute Liver Failure Treatment Revenue, 2017-2028
  6.5.2 China Acute Liver Failure Treatment Market Size, 2017-2028
  6.5.3 Japan Acute Liver Failure Treatment Market Size, 2017-2028
  6.5.4 South Korea Acute Liver Failure Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Acute Liver Failure Treatment Market Size, 2017-2028
  6.5.6 India Acute Liver Failure Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Acute Liver Failure Treatment Revenue, 2017-2028
  6.6.2 Brazil Acute Liver Failure Treatment Market Size, 2017-2028
  6.6.3 Argentina Acute Liver Failure Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Acute Liver Failure Treatment Revenue, 2017-2028
  6.7.2 Turkey Acute Liver Failure Treatment Market Size, 2017-2028
  6.7.3 Israel Acute Liver Failure Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Acute Liver Failure Treatment Market Size, 2017-2028
  6.7.5 UAE Acute Liver Failure Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Corporate Summary
  7.1.2 Novartis AG Business Overview
  7.1.3 Novartis AG Acute Liver Failure Treatment Major Product Offerings
  7.1.4 Novartis AG Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis AG Key News
7.2 Bayer AG
  7.2.1 Bayer AG Corporate Summary
  7.2.2 Bayer AG Business Overview
  7.2.3 Bayer AG Acute Liver Failure Treatment Major Product Offerings
  7.2.4 Bayer AG Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bayer AG Key News
7.3 Cardiorentis AG
  7.3.1 Cardiorentis AG Corporate Summary
  7.3.2 Cardiorentis AG Business Overview
  7.3.3 Cardiorentis AG Acute Liver Failure Treatment Major Product Offerings
  7.3.4 Cardiorentis AG Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.3.5 Cardiorentis AG Key News
7.4 Cytokinetics, Inc.
  7.4.1 Cytokinetics, Inc. Corporate Summary
  7.4.2 Cytokinetics, Inc. Business Overview
  7.4.3 Cytokinetics, Inc. Acute Liver Failure Treatment Major Product Offerings
  7.4.4 Cytokinetics, Inc. Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.4.5 Cytokinetics, Inc. Key News
7.5 Orion Corporation
  7.5.1 Orion Corporation Corporate Summary
  7.5.2 Orion Corporation Business Overview
  7.5.3 Orion Corporation Acute Liver Failure Treatment Major Product Offerings
  7.5.4 Orion Corporation Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.5.5 Orion Corporation Key News
7.6 Bristol-Myers Squibb Company
  7.6.1 Bristol-Myers Squibb Company Corporate Summary
  7.6.2 Bristol-Myers Squibb Company Business Overview
  7.6.3 Bristol-Myers Squibb Company Acute Liver Failure Treatment Major Product Offerings
  7.6.4 Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bristol-Myers Squibb Company Key News
7.7 PhaseBio Pharmaceuticals, InC
  7.7.1 PhaseBio Pharmaceuticals, InC Corporate Summary
  7.7.2 PhaseBio Pharmaceuticals, InC Business Overview
  7.7.3 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Major Product Offerings
  7.7.4 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.7.5 PhaseBio Pharmaceuticals, InC Key News
7.8 Merck & Co
  7.8.1 Merck & Co Corporate Summary
  7.8.2 Merck & Co Business Overview
  7.8.3 Merck & Co Acute Liver Failure Treatment Major Product Offerings
  7.8.4 Merck & Co Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.8.5 Merck & Co Key News
7.9 CVie Therapeutics Limited
  7.9.1 CVie Therapeutics Limited Corporate Summary
  7.9.2 CVie Therapeutics Limited Business Overview
  7.9.3 CVie Therapeutics Limited Acute Liver Failure Treatment Major Product Offerings
  7.9.4 CVie Therapeutics Limited Acute Liver Failure Treatment Revenue in Global Market (2017-2022)
  7.9.5 CVie Therapeutics Limited Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acute Liver Failure Treatment Market Opportunities & Trends in Global Market
Table 2. Acute Liver Failure Treatment Market Drivers in Global Market
Table 3. Acute Liver Failure Treatment Market Restraints in Global Market
Table 4. Key Players of Acute Liver Failure Treatment in Global Market
Table 5. Top Acute Liver Failure Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acute Liver Failure Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acute Liver Failure Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acute Liver Failure Treatment Product Type
Table 9. List of Global Tier 1 Acute Liver Failure Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Liver Failure Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acute Liver Failure Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acute Liver Failure Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acute Liver Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acute Liver Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acute Liver Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acute Liver Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acute Liver Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Acute Liver Failure Treatment Product Offerings
Table 32. Novartis AG Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer AG Corporate Summary
Table 34. Bayer AG Acute Liver Failure Treatment Product Offerings
Table 35. Bayer AG Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Cardiorentis AG Corporate Summary
Table 37. Cardiorentis AG Acute Liver Failure Treatment Product Offerings
Table 38. Cardiorentis AG Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Cytokinetics, Inc. Corporate Summary
Table 40. Cytokinetics, Inc. Acute Liver Failure Treatment Product Offerings
Table 41. Cytokinetics, Inc. Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Orion Corporation Corporate Summary
Table 43. Orion Corporation Acute Liver Failure Treatment Product Offerings
Table 44. Orion Corporation Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Company Corporate Summary
Table 46. Bristol-Myers Squibb Company Acute Liver Failure Treatment Product Offerings
Table 47. Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 48. PhaseBio Pharmaceuticals, InC Corporate Summary
Table 49. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Product Offerings
Table 50. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co Corporate Summary
Table 52. Merck & Co Acute Liver Failure Treatment Product Offerings
Table 53. Merck & Co Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 54. CVie Therapeutics Limited Corporate Summary
Table 55. CVie Therapeutics Limited Acute Liver Failure Treatment Product Offerings
Table 56. CVie Therapeutics Limited Acute Liver Failure Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Acute Liver Failure Treatment Segment by Type in 2021
Figure 2. Acute Liver Failure Treatment Segment by Application in 2021
Figure 3. Global Acute Liver Failure Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acute Liver Failure Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acute Liver Failure Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Liver Failure Treatment Revenue in 2021
Figure 8. By Type - Global Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 12. US Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 24. China Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acute Liver Failure Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acute Liver Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer AG Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cardiorentis AG Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cytokinetics, Inc. Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Orion Corporation Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CVie Therapeutics Limited Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)